Effect of Open Chain Versus Closed Chain Segmental Control Exercises on CSA of Lumbar Multifidus Muscle in Chronic MLBP
Launched by CAIRO UNIVERSITY · Aug 18, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different types of exercises can help people with chronic low back pain. The researchers want to see if adding "open chain" exercises (where your arms or legs are free to move) or "closed chain" exercises (where your arms or legs are in contact with a surface) to standard treatment can improve pain levels, how well you can move your lower back, and the size of a muscle called the multifidus, which supports the spine.
To join the trial, you need to be between 25 and 55 years old and have had low back pain for more than six months. You should be able to follow instructions and perform exercises. However, if you have a serious neurological or orthopedic disease, a psychological disorder, are pregnant, or have had certain spinal surgeries, you won't be eligible to participate. If you qualify, you can expect to engage in exercise routines and contribute to research that may help others with similar back pain issues in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with chronic low back pain from both genders their age will be ranged and divided into three groups from 25-55 years.
- • 2. Participants with chronic low back pain lasting for more than 6 Months.
- • 3. A patient who can follow the command.
- • 4. A patient who can do exercise.
- Exclusion Criteria:
- • 1. Low back pain patients with a history of severe neurological disease or orthopedic disease.
- • 2. History of Psychological Disorder.
- • 3. Unhealthy Patient.
- • 4. Pregnant women.
- • 5. Patient with a spinal tumor.
- • 6. History of any operation related to spine. Ex. Vertebral fracture or dislocation.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Dokki, Egypt
Patients applied
Trial Officials
Haytham M Elhafez, PhD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported